Mortality in alpha-1-antitrypsin deficiency in the United Kingdom

Respiratory Medicine

Volumn 103, Issue 10, 2009, Pages 1540-1547

  Dawkins, Paul ^a   Wood, Alice ^a   Nightingale, Peter ^a   Stockley, Robert ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Alpha 1 antitrypsin deficiency; Cause of death; Computerised tomography; Lung function; Mortality; Registry

Indexed keywords

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEATH CERTIFICATE; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LIVER DISEASE; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; OCCUPATION; PHENOTYPE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; TOTAL LUNG CAPACITY; UNITED KINGDOM;

ALPHA 1-ANTITRYPSIN DEFICIENCY; CAUSE OF DEATH; FEMALE; FORCED EXPIRATORY VOLUME; GREAT BRITAIN; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PULMONARY EMPHYSEMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 69249228595     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.04.004     Document Type: Article

References (27)

1. Stoller J.K., Tomashefski Jr. J., Crystal R.G., Arroliga A., Strange C., Killian D.N., et al. Mortality in individuals with severe deficiency of alpha1-antitrypsin: findings from the National Heart, Lung, and Blood Institute Registry. Chest 127 4 (2005 Apr) 1196-1204
2. 1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med 158 1 (1998 Jul) 49-59
3. 1. The Lung Health Study. JAMA 272 19 (1994 Nov 16) 1497-1505
4. Ebi-Kryston K.L. Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study. J Clin Epidemiol 41 3 (1988) 251-260
5. Hole D.J., Watt G.C., Davey-Smith G., Hart C.L., Gillis C.R., and Hawthorne V.M. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 313 7059 (1996 Sep 21) 711-715
6. Krzyzanowski M., and Wysocki M. The relation of thirteen-year mortality to ventilatory impairment and other respiratory symptoms: the Cracow Study. Int J Epidemiol 15 1 (1986 Mar) 56-64
7. Peto R., Speizer F.E., Cochrane A.L., Moore F., Fletcher C.M., Tinker C.M., et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis 128 3 (1983 Sep) 491-500
8. Sin D.D., Wu L., and Man S.F. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 127 6 (2005 Jun) 1952-1959
9. Tockman M.S., and Comstock G.W. Respiratory risk factors and mortality: longitudinal studies in Washington County, Maryland. Am Rev Respir Dis 140 3 Pt 2 (1989 Sep) S56-S63
10. Traver G.A., Cline M.G., and Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study. Am Rev Respir Dis 119 6 (1979 Jun) 895-902
11. Dawkins P.A., Dowson L.J., Guest P.J., and Stockley R.A. Predictors of mortality in alpha1-antitrypsin deficiency. Thorax 58 12 (2003 Dec) 1020-1026
12. 1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT Study Group. Eur Respir J 10 10 (1997 Oct) 2260-2263
13. Wencker M., Fuhrmann B., Banik N., and Konietzko N. Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor. Chest 119 3 (2001 Mar) 737-744
14. Lantz P.M., House J.S., Lepkowski J.M., Williams D.R., Mero R.P., and Chen J. Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults. JAMA 279 21 (1998 Jun 3) 1703-1708
15. Marmot M.G., Shipley M.J., and Rose G. Inequalities in death-specific explanations of a general pattern?. Lancet 1 8384 (1984 May 5) 1003-1006
16. Pappas G., Queen S., Hadden W., and Fisher G. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med 329 2 (1993 Jul 8) 103-109
17. Guidelines for the measurement of respiratory function. Recommendations of the British Thoracic Society and the Association of Respiratory Technicians and Physiologists. Respir Med 88 3 (1994 Mar) 165-194
18. Macintyre N., Crapo R.O., Viegi G., Johnson D.C., van der Grinten C.P., Brusasco V., et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26 4 (2005 Oct) 720-735
19. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., et al. Standardisation of spirometry. Eur Respir J 26 2 (2005 Aug) 319-338
20. Wanger J., Clausen J.L., Coates A., Pedersen O.F., Brusasco V., Burgos F., et al. Standardisation of the measurement of lung volumes. Eur Respir J 26 3 (2005 Sep) 511-522
21. Parr D.G., Stoel B.C., Stolk J., and Stockley R.A. Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency. Thorax 61 6 (2006 Jun) 485-490
22. Larsson C. Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z. Acta Med Scand 204 5 (1978) 345-351
23. Tanash H.A., Nilsson P.M., Nilsson J.A., and Piitulainen E. Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ). Thorax (2008 Aug 5) [epub ahead of print]
24. Casanova C., Cote C., de Torres J.P., Guirre-Jaime A., Marin J.M., Pinto-Plata V., et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171 6 (2005 Mar 15) 591-597
25. Holme J., and Stockley R.A. Radiologic and clinical features of COPD patients with discordant pulmonary physiology: lessons from alpha1-antitrypsin deficiency. Chest 132 3 (2007 Sep) 909-915
26. Parr D.G., Stoel B.C., Stolk J., and Stockley R.A. Pattern of emphysema distribution in alpha1-antitrypsin deficiency influences lung function impairment. Am J Respir Crit Care Med 170 11 (2004 Dec 1) 1172-1178
27. McGarvey L.P., John M., Anderson J.A., Zvarich M., and Wise R.A. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 62 5 (2007 May) 411-415